Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Pompe disease is an extremely rare disorder in Japan, making the task of assessing epidemiology, diagnosis, and understanding patient needs complex.

This white paper, researched by Informa Pharma Intelligence highlights important insights that will support the development of new treatment options.

Clinical characteristics of Pompe disease
Diagnostic testing processes
Patient journey from symptom onset to diagnosis
Diagnostic challenges associated with Pompe disease
Currently available drug therapy and unmet needs

Download this white paper for the latest research into the current state of this rare disease.

Please provide your contact information to access your white paper.

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio
By ticking this box, you agree to receive emails such as promotional offers from other members of the Informa group and selected 3rd party companies